C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
暂无分享,去创建一个
[1] D. Maraganore,et al. Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease , 2014, Neurology.
[2] Kevin F. Bieniek,et al. Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia. , 2014, JAMA neurology.
[3] Nick C Fox,et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.
[4] C. van Broeckhoven,et al. A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories , 2014, Journal of Medical Genetics.
[5] J. Hodges,et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. , 2014, JAMA neurology.
[6] P. Gleeson,et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking , 2014, Human molecular genetics.
[7] J. Kirby,et al. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype , 2014, Acta Neuropathologica.
[8] P. McColgan,et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies , 2014, Neurology.
[9] G. Forloni,et al. C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study. , 2013, Journal of Alzheimer's disease : JAD.
[10] E. Kremmer,et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins , 2013, Acta Neuropathologica.
[11] L. Petrucelli,et al. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study , 2013, The Lancet Neurology.
[12] C. Broeckhoven,et al. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum , 2013, Trends in Neurosciences.
[13] Z. Zou,et al. Screening for C9orf72 repeat expansions in Chinese amyotrophic lateral sclerosis patients , 2013, Neurobiology of Aging.
[14] A. Higginbottom,et al. Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation , 2013, Molecular Neurodegeneration.
[15] C. Ki,et al. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis , 2013, Neurobiology of Aging.
[16] E. Kremmer,et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.
[17] P. Johannsen,et al. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease , 2013, Clinical genetics.
[18] Nick C Fox,et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. , 2013, American journal of human genetics.
[19] C. van Broeckhoven,et al. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. , 2013, JAMA neurology.
[20] C. Broeckhoven,et al. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations , 2013, Acta Neuropathologica.
[21] Timothy P. Levine,et al. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs , 2013, Bioinform..
[22] L. Aravind,et al. Discovery of Novel DENN Proteins: Implications for the Evolution of Eukaryotic Intracellular Membrane Structures and Human Disease , 2012, Front. Gene..
[23] P. S. St George-Hyslop,et al. Investigation of c9orf72 in 4 neurodegenerative disorders. , 2012, Archives of neurology.
[24] F. Jessen,et al. A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats , 2012, Human mutation.
[25] A. Singleton,et al. Large C9orf72 repeat expansions are not a common cause of Parkinson's disease , 2012, Neurobiology of Aging.
[26] Hitoshi Takahashi,et al. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72 , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[27] Nick C Fox,et al. Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions , 2012, Alzheimer's Research & Therapy.
[28] D. Geschwind,et al. Frontotemporal dementia due to C9ORF72 mutations , 2012, Neurology.
[29] P. Tsai,et al. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan , 2012, Neurobiology of Aging.
[30] B. Boeve,et al. Cognitive and behavioral features of c9FTD/ALS , 2012, Alzheimer's Research & Therapy.
[31] Michelle K. Lupton,et al. The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder , 2012, European Journal of Human Genetics.
[32] Janel O. Johnson,et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.
[33] F. Marrosu,et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. , 2012, Brain : a journal of neurology.
[34] C. Jack,et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics , 2012, Brain : a journal of neurology.
[35] David T. Jones,et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 , 2012, Brain : a journal of neurology.
[36] S. Pereson,et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study , 2012, The Lancet Neurology.
[37] A. Singleton,et al. Repeat expansion in C9ORF72 in Alzheimer's disease. , 2012, The New England journal of medicine.
[38] A. Eisen,et al. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p , 2012, Acta Neuropathologica.
[39] T. Ferman,et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 , 2011, Acta Neuropathologica.
[40] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[41] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[42] Bruce L. Miller,et al. Frontotemporal lobar degeneration , 2010, CNS drugs.
[43] J R Hodges,et al. The prevalence of frontotemporal dementia , 2002, Neurology.
[44] O. Hardiman,et al. Incidence and prevalence of ALS in Ireland, 1995–1997 , 1999, Neurology.
[45] S. Chin,et al. Amyotrophy in prion diseases. , 2000, Archives of neurology.